Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Griffith Perkins

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Allergy and Clinical Immunology|June 29, 2021
ReplyGriffith Perkins, Alexander Troelnikov, Pravin Hissaria
The Journal of Allergy and Clinical Immunology|May 15, 2021
Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergyAlexander Troelnikov, Griffith Perkins, Chino Yuson, et al.
Gut|July 27, 2023
B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated miceTodd Norton, Miriam Anne Lynn, Charné Rossouw, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 11, 2022
AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergySyed B Ali, Griffith Perkins, Dongjae Ryoo, et al.
Internal Medicine Journal|July 18, 2022
COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South AustraliaMatthew Tunbridge, Griffith Perkins, Maverick Lee, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Allergy and Clinical Immunology|June 29, 2021
ReplyGriffith Perkins, Alexander Troelnikov, Pravin Hissaria
The Journal of Allergy and Clinical Immunology|May 15, 2021
Basophil reactivity to BNT162b2 is mediated by PEGylated lipid nanoparticles in patients with PEG allergyAlexander Troelnikov, Griffith Perkins, Chino Yuson, et al.
Gut|July 27, 2023
B and T cell responses to the BNT162b2 COVID-19 mRNA vaccine are not impaired in germ-free or antibiotic-treated miceTodd Norton, Miriam Anne Lynn, Charné Rossouw, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|March 11, 2022
AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergySyed B Ali, Griffith Perkins, Dongjae Ryoo, et al.
Internal Medicine Journal|July 18, 2022
COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South AustraliaMatthew Tunbridge, Griffith Perkins, Maverick Lee, et al.
Pageof 1